Acta Neurochirurgica

, Volume 159, Issue 1, pp 123–130 | Cite as

Translabyrinthine vestibular neurectomy and simultaneous cochlear implant for Ménière’s disease

  • Pietro CanziEmail author
  • Marco Manfrin
  • Marco Perotti
  • Federico Aprile
  • Silvia Quaglieri
  • Elisabetta Rebecchi
  • Giulia Locatelli
  • Marco Benazzo
Clinical Article - Neurosurgical Techniques



Surgical management of Ménière’s disease (MD) is recommended in case of medical and intratympanic treatment failures. Translabyrinthine vestibular nerve section has been considered the gold standard for denervation procedures in order to control vertigo attacks, although at the cost of sacrificing residual hearing. To the best of our knowledge, no work has been published with regard to a group of patients submitted to translabyrinthine vestibular neurectomy and simultaneous cochlear implant for MD. The aim of the present study was to assess the effectiveness of translabyrinthine vestibular nerve section and simultaneous cochlear implant in a prospective study.


All adult patients (over 18 years of age) with a diagnosis of intractable unilateral definite MD and useless residual hearing function were enrolled after medical and intratympanic treatment failures. Pre- and postoperative otoneurological evaluation concerned: frequency of vertigo attacks, head impulse test and caloric testing, pure tone average and speech perception audiometry in quiet conditions, tinnitus handicap inventory test, functional level scale and rate of vertigo control, dizziness handicap inventory test, and MD patient-oriented severity index. At least 6 months of follow-up were needed to be enrolled in the study.


Four patients were included in the study. Translabyrinthine vestibular nerve section and simultaneous cochlear implant seemed to considerably improve the disabling effects of MD, achieving a good control of vestibular symptoms (mean pre/postoperative vertigo attacks per month: 16.5/0), resolving hearing loss (mean pre/postoperative pure tone average in the affected ear: 86.2/32.5 dB), improving the tinnitus (mean pre/postoperative tinnitus handicap inventory test: 77.2/6), and finally increasing the overall quality-of-life parameters.


In our preliminary report, translabyrinthine vestibular nerve section and simultaneous cochlear implant showed encouraging results in order to definitively control both vestibular and cochlear symptoms during the same therapeutic procedure.


Cochlear implant Translabyrinthine neurectomy Nerve section Ménière’s disease 


Compliance with ethical standards

Conflict of interest


Informed consent

Informed consent was obtained from all individual participants included in the study.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

This article does not contain any studies with animals performed by any of the authors.

Supplementary material

Translabyrinthine vestibular neurectomy and simultaneous cochlear implant (MP4 153997 kb)


  1. 1.
    Aksoy S, Firat Y, Alpar R (2007) The Tinnitus Handicap Inventory: a study of validity and reliability. Int Tinnitus J 13:94–98PubMedGoogle Scholar
  2. 2.
    Albera R, Canale A, Parandero F, Ducati A, Lanotte M (2011) Surgical indication in Ménière’s disease therapy: clinical and epidemiological aspects. Eur Arch Otorhinolaryngol 268:967–972CrossRefPubMedGoogle Scholar
  3. 3.
    Basura GJ, Lin GC, Telian SA (2014) Comparison of second-echelon treatments for Ménière’s disease. JAMA Otolaryngol Head Neck Surg 140:754–761CrossRefPubMedGoogle Scholar
  4. 4.
    Berryhill W, Graham M (2002) Chemical and physical labyrinthectomy for Ménière’s disease. Otolaryngol Clin N Am 35:675–682CrossRefGoogle Scholar
  5. 5.
    Brandt T, Strupp M, Dieterich M (2016) Vestibular paroxysmia: a treatable neurovascular cross-compression syndrome. J Neurol 263:90–96CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Bretlau P, Thomsen J, Tos M, Johnsen NJ (1989) Placebo effect in surgery for Ménière’s disease: nine-year follow-up. Am J Otol 10:259–261PubMedGoogle Scholar
  7. 7.
    Brookes G (1997) The role of vestibular nerve section in Ménière’s disease. Ear Nose Throat J 76:652–656, 658–659, 663Google Scholar
  8. 8.
    Casani AP, Cerchiai N, Navari E, Dallan I, Piaggi P, Sellari-Franceschini S (2014) Intratympanic gentamicin for Ménière’s disease: short- and long-term follow-up of two regimens of treatment. Otolaryngol Head Neck Surg 150:847–852CrossRefPubMedGoogle Scholar
  9. 9.
    Casani AP, Piaggi P, Cerchiai N, Seccia V, Sellari-Franceschini S, Dallan I (2012) Intratympanic treatment of intractable unilateral Ménière disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg 146:430–437CrossRefPubMedGoogle Scholar
  10. 10.
    Committee on Hearing and Equilibrium (1995) Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 113:181–185Google Scholar
  11. 11.
    Dandy W (1928) Ménière’s disease: its diagnosis and a method of treatment. Arch Surg 16:1127–1152CrossRefGoogle Scholar
  12. 12.
    Dandy W (1941) The surgical treatment of Ménière’s disease. Surg Gynecol Obstet 72:421–425Google Scholar
  13. 13.
    De la Cruz A, Teufert KB, Berliner KI (2007) Transmastoid labyrinthectomy versus translabyrinthine vestibular nerve section: does cutting the vestibular nerve make a difference in outcome? Otol Neurotol 28:801–808CrossRefGoogle Scholar
  14. 14.
    Deveze A, Bernard-Demanze L, Xavier F, Lavieille J-P, Elziere M (2014) Vestibular compensation and vestibular rehabilitation. Current concepts and new trends. Neurophysiol Clin 44:49–57CrossRefPubMedGoogle Scholar
  15. 15.
    Duracinsky M, Mosnier I, Bouccara D, Sterkers O, Chassany O (2007) Literature review of questionnaires assessing vertigo and dizziness, and their impact on patients’ quality of life. Value Health 10:273–284CrossRefPubMedGoogle Scholar
  16. 16.
    Eddington DK, Dobelle WH, Brackmann DE, Mladejovsky MG, Parkin JL (1978) Auditory prostheses research with multiple channel intracochlear stimulation in man. Ann Otol Rhinol Laryngol 87:1–39PubMedGoogle Scholar
  17. 17.
    Fisch U (1996) Transtemporal supralabyrinthine (middle cranial fossa) vestibular neurectomy: a review of the last 100 cases. Skull Base Surg 6:221–225CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Fujita N, Nario K, Yamanaka T, Ueda T, Matsunaga T (1998) Neurovascular compression syndrome with Ménière’s disease—a report of the treatment of a patient with microvascular decompression. Auris Nasus Larynx 25:203–207CrossRefPubMedGoogle Scholar
  19. 19.
    Furukawa M, Kitahara T, Horii A, Uno A, Imai T, Ohta Y, Morihana T, Inohara H, Mishiro Y, Sakagami M (2013) Psychological condition in patients with intractable Ménière’s disease. Acta Otolaryngol 133:584–589CrossRefPubMedGoogle Scholar
  20. 20.
    Gates G, Verrall A (2005) Validation of the Ménière’s disease patient-oriented symptom-severity index. Arch Otolaryngol Head Neck Surg 131:863–867CrossRefPubMedGoogle Scholar
  21. 21.
    Gates GA (2000) Clinimetrics of Ménière’s disease. Laryngoscope 110:8–11CrossRefPubMedGoogle Scholar
  22. 22.
    Ghossaini S, Wazen J (2006) An update on the surgical treatment of Ménière’s diseases. J Am Acad Audiol 17:38–44CrossRefPubMedGoogle Scholar
  23. 23.
    Glasscock M, Nashville T (1973) Vestibular nerve section. Middle fossa and translabyrinthine. Arch Otolaryngol 97:112–114CrossRefPubMedGoogle Scholar
  24. 24.
    Glasscock ME, Hughes GB, Davis WE, Jackson CG (1984) Labyrinthectomy versus middle fossa vestibular nerve section in Ménière’s disease. A critical evaluation of relief of vertigo. Ann Otol Rhinol Laryngol 89:318–324CrossRefGoogle Scholar
  25. 25.
    Glasscock ME, Jackson CG, Poe DS, Johnson GD (1989) What I think of sac surgery in 1989. Am J Otol 10:230–233PubMedGoogle Scholar
  26. 26.
    Hansen MR, Gantz BJ, Dunn C (2013) Outcomes after cochlear implantation for patients with single-sided deafness, including those with recalcitrant Ménière’s disease. Otol Neurotol 34:1681–1687CrossRefPubMedGoogle Scholar
  27. 27.
    Holden LK, Neely JG, Gotter BD, Mispagel KM, Firszt JB (2012) Sequential bilateral cochlear implantation in a patient with bilateral Ménière’s disease. J Am Acad Audiol 23:256–268CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Huang TS (1987) Valve implants compared to other surgical methods. Am J Otol 8:301–306CrossRefPubMedGoogle Scholar
  29. 29.
    Huang TS (1999) Three new surgeries for treatment of intractable Ménière’s disease. Am J Otol 20:233–237PubMedGoogle Scholar
  30. 30.
    Jacobson G, Newman CW (1990) The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg 116:424–427CrossRefPubMedGoogle Scholar
  31. 31.
    Jennings R, Reams C, Jacobson J, Cole J (1989) Results of surgical treatment for Ménière’s disease. Otolaryngol Head Neck Surg 100:195–199CrossRefPubMedGoogle Scholar
  32. 32.
    Jung TT, Anderson JH, Paparella MM (1987) Cochleovestibular nerve sections in labyrinthectomized patients. Am J Otol 8:155–158PubMedGoogle Scholar
  33. 33.
    Kaylie DM, Jackson CG, Gardner EK (2005) Surgical management of Ménière’s disease in the era of gentamicin. Otolaryngol Head Neck Surg 132:443–450CrossRefPubMedGoogle Scholar
  34. 34.
    Kveton JF (2006) Revision surgery for vertigo. Otolaryngol Clin N Am 39:741–750CrossRefGoogle Scholar
  35. 35.
    Langman AW, Lindeman RC (1993) Surgery for vertigo in the nonserviceable hearing ear: transmastoid labyrinthectomy or translabyrinthine vestibular nerve section. Laryngoscope 103:1321–1325PubMedGoogle Scholar
  36. 36.
    Lassaletta L, Aristegui M, Medina M, Aranguez G, Pérez-Mora RM, Falcioni M, Gavilán J, Piazza P, Sanna M (2014) Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best hearing ear and in patients with NF2. Eur Arch Otorhinolaryngol. doi: 10.1007/s00405-014-3450-3 Google Scholar
  37. 37.
    Levine SC (2002) Vestibular nerve section. Oper Tech Otolaryngol Head Neck Surg 12:137–140CrossRefGoogle Scholar
  38. 38.
    Levine SC, Glasscock M, McKennan KX (1990) Long-term results of labyrinthectomy. Laryngoscope 100:125–127PubMedGoogle Scholar
  39. 39.
    Linthicum FH, Alonso A, Denia A (1979) Traumatic neuroma: a complication of transcanal labyrinthectomy. Arch Otolaryngol 105:654–655CrossRefPubMedGoogle Scholar
  40. 40.
    Lloyd SK, Glynn FJ, Rutherford SA, King AT, Mawman DJ, O’Driscoll MP, Evans DG, Ramsden RT, Freeman SR (2014) Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2. Otol Neurotol 35:43–51CrossRefPubMedGoogle Scholar
  41. 41.
    Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A, Classification Committee of the Barany Society, Japan Society for Equilibrium Research, European Academy of Otology and Neurotology (EAONO), Equilibrium Committee of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), Korean Balance Society (2015) Diagnostic criteria for Ménière’s disease. J Vestib Res 25:1–7PubMedGoogle Scholar
  42. 42.
    Lustig LR, Yeagle J, Niparko JK, Minor LB (2003) Cochlear implantation in patients with bilateral Ménière’s syndrome. Otol Neurotol 24:397–403CrossRefPubMedGoogle Scholar
  43. 43.
    MacKeith SAC, Bottrill ID, Ramsden JD (2014) Simultaneous labyrinthectomy with cochlear implantation in patients with bilateral Ménière’s disease. Ann Otol Rhinol Laryngol 123:485–489CrossRefPubMedGoogle Scholar
  44. 44.
    Mancini F, Catalani M, Carru M, Monti B (2002) History of Ménière’s disease and its clinical presentation. Otolaryngol Clin N Am 35:565–580CrossRefGoogle Scholar
  45. 45.
    Mick P, Amoodi H, Arnoldner C, Shipp D, Friesen L, Lin V, Nedzelski J, Chen J (2014) Cochlear implantation in patients with advanced Ménière’s disease. Otol Neurotol 35:1172–1178CrossRefPubMedGoogle Scholar
  46. 46.
    Møller AR, Møller MB (2007) Microvascular decompression operations. Prog Brain Res 166:397–400CrossRefPubMedGoogle Scholar
  47. 47.
    Møller MB, Møller AR, Jannetta PJ, Jho HD, Sekhar LN (1993) Microvascular decompression of the eighth nerve in patients with disabling positional vertigo: selection criteria and operative results in 207 patients. Acta Neurochir (Wien) 125:75–82CrossRefGoogle Scholar
  48. 48.
    Monsell EM, Brackmann DE, Linthicum FH (1988) Why do vestibular destructive procedures sometimes fail? Otolaryngol Head Neck Surg 99:472–479CrossRefPubMedGoogle Scholar
  49. 49.
    Monzani D, Genovese E, Marrara A, Gherpelli C, Pingani L, Forghieri M, Rigatelli M, Guadagnin T, Arslan E (2008) Validity of the Italian adaptation of the Tinnitus Handicap Inventory; focus on quality of life and psychological distress in tinnitus sufferers. Acta Otorhinolaryngol Ital 28:126–134PubMedPubMedCentralGoogle Scholar
  50. 50.
    Murphy M, Gates G (1999) Measuring the effects of Ménière’s disease: results of the Patient-Oriented Severity Index (MD POSI) version 1. Ann Otol Rhinol Laryngol 108:331–337CrossRefPubMedGoogle Scholar
  51. 51.
    Nelson R (2001) Translabyrinthine vestibular neurectomy. In: Brackmann DE, Shelton C, Arriaga MA (eds) Otologic surgery, 2nd edn. WB Saunders, Philadelphia, pp 433–439Google Scholar
  52. 52.
    Newman CW, Jacobson GP, Spitzer JB (1996) Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg 122:143–148CrossRefPubMedGoogle Scholar
  53. 53.
    Norré M, Forrez G, Beckers A (1987) Vestibular dysfunction causing instability in aged patients. Acta Otolaryngol 104:50–55CrossRefPubMedGoogle Scholar
  54. 54.
    Ozdoğmuş O, Sezen O, Kubilay U, Saka E, Duman U, San T, Cavdar S (2004) Connections between the facial, vestibular and cochlear nerve bundles within the internal auditory canal. J Anat 205:65–75CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Paparella MM, Fina M (2002) Endolymphatic sac enhancement: reversal of pathogenesis. Otolaryngol Clin N Am 35:621–637CrossRefGoogle Scholar
  56. 56.
    Pappas DG (1997) Vestibular nerve section: long term follow-up. Laryngoscope 107:1203–1209CrossRefPubMedGoogle Scholar
  57. 57.
    Portmann G (1927) The saccus endolymphaticus and an operation for draining for the relief of vertigo. R Soc Med 20:1862–1867Google Scholar
  58. 58.
    Pullens B, Verschuur HP, Van Benthem PP (2013) Surgery for Ménière’s disease. Cochrane Database Syst Rev 2:1–19Google Scholar
  59. 59.
    Quaglieri S, Gatti O, Rebecchi E, Manfrin M, Tinelli C, Mira E, Benazzo M (2014) Intratympanic gentamicin treatment “as needed” for Ménière’s disease. Long-term analysis using the Kaplan–Meier method. Eur Arch Otorhinolaryngol 271:1443–1449CrossRefPubMedGoogle Scholar
  60. 60.
    Rauch S (2010) Clinical hints and precipitating factors in patients suffering from Ménière’s disease. Otolaryngol Clin N Am 43:1011–1017CrossRefGoogle Scholar
  61. 61.
    Reid CB, Eisenberg R, Halmagyi GM, Fagan PA (1996) The outcome of vestibular nerve section for intractable vertigo: the patient’s point of view. Laryngoscope 106:1553–1556CrossRefPubMedGoogle Scholar
  62. 62.
    Sajjadi H, Paparella MM (2008) Ménière’s disease. Lancet 372:406–414CrossRefPubMedGoogle Scholar
  63. 63.
    Schuknecht H (1956) Ablation therapy for the relief of Ménière’s disease. Laryngoscope 66:859–870CrossRefPubMedGoogle Scholar
  64. 64.
    Semaan MT, Megerian CA (2011) Ménière’s disease: a challenging and relentless disorder. Otolaryngol Clin N Am 44:383–403CrossRefGoogle Scholar
  65. 65.
    Semaan MT, Zheng QY, Han F, Zheng Y, Yu H, Heaphy JC, Megerian CA (2013) Characterization of neuronal cell death in the spiral ganglia of a mouse model of endolymphatic hydrops. Otol Neurotol 34:559–569CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Silverstein H, Jackson LE (2002) Vestibular nerve section. Otolaryngol Clin N Am 35:655–673CrossRefGoogle Scholar
  67. 67.
    Silverstein H, Norrell H, Smouha E, Jones R, Rosenberg S (1990) An evolution of approach in vestibular neurectomy. Otolaryngol Head Neck Surg 102:374–381CrossRefPubMedGoogle Scholar
  68. 68.
    Silverstein H, Smouha E, Jones R (1989) Natural history vs. surgery for Ménière’s disease. Otolaryngol Head Neck Surg 100:6–16CrossRefPubMedGoogle Scholar
  69. 69.
    Sood AJ, Lambert PR, Nguyen SA, Meyer TA (2014) Endolymphatic sac surgery for Ménière’s disease: a systematic review and meta-analysis. Otol Neurotol 35:1033–1045CrossRefPubMedGoogle Scholar
  70. 70.
    Stokroos R, Kingma H (2004) Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Ménière’s disease: a prospective, double-blind, placebo- controlled, randomized clinical trial. Acta Otolaryngol 124:172–175CrossRefPubMedGoogle Scholar
  71. 71.
    Teufert KB, Berliner KI, De la Cruz A (2007) Persistent dizziness after surgical treatment of vertigo: an exploratory study of prognostic factors. Otol Neurotol 28:1056–1062CrossRefPubMedGoogle Scholar
  72. 72.
    Teufert KB, Doherty J (2010) Endolymphatic sac shunt, labyrinthectomy, and vestibular nerve section in Ménière’s disease. Otolaryngol Clin N Am 43:1091–1111CrossRefGoogle Scholar
  73. 73.
    Thomsen J, Bonding P, Becker B, Stage J, Tos M (1998) The non-specific effect of endolymphatic sac surgery in treatment of Ménière’s disease: a prospective, randomized controlled study comparing “classic” endolymphatic sac surgery with the insertion of a ventilating tube in the tympanic membrane. Acta Otolaryngol 118:769–773CrossRefPubMedGoogle Scholar
  74. 74.
    Thomsen J, Bretlau P, Tos M, Johnsen NJ (1981) Placebo effect in surgery for Ménière’s disease. A double-blind, placebo-controlled study on endolymphatic sac shunt surgery. Arch Otolaryngol 107:271–277CrossRefPubMedGoogle Scholar
  75. 75.
    Van de Heyning P, Vermeire K, Diebl M, Nopp P, Anderson I, De Ridder D (2008) Incapacitating unilateral tinnitus in single-sided deafness treated by cochlear implantation. Ann Otol Rhinol Laryngol 117:645–652CrossRefPubMedGoogle Scholar
  76. 76.
    Vermeire K, Van Yper L, De Vel E, Dhooge I (2014) Is cochlear implantation an effective treatment for Ménière’s disease? B-ENT 10:93–98PubMedGoogle Scholar
  77. 77.
    Wareing M, O’Connor A (1997) The role of labyrinthectomy and cochlear implantation in Ménière’s disease. Ear Nose Throat J 76:664–672PubMedGoogle Scholar
  78. 78.
    Ylikoski J, Belal A (1981) Human vestibular nerve morphology and labyrinthectomy. Am J Otolaryngol 2:81–93CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2016

Authors and Affiliations

  • Pietro Canzi
    • 1
    Email author
  • Marco Manfrin
    • 1
  • Marco Perotti
    • 2
  • Federico Aprile
    • 1
  • Silvia Quaglieri
    • 1
  • Elisabetta Rebecchi
    • 1
  • Giulia Locatelli
    • 1
  • Marco Benazzo
    • 1
  1. 1.Department of OtorhinolaryngologyUniversity of Pavia, IRCCS Policlinico “S. Matteo” FoundationPaviaItaly
  2. 2.Neurosurgery UnitOspedale Civile “SS Antonio Biagio and C. Arrigo”AlessandriaItaly

Personalised recommendations